Vergleich

Inhibitors & Compound Libraries

609594 Artikel

pro Seite

Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge Preis
BMS-­986120 Inhibitors Other DCC-DC11923-100mg

DCChemicals
100 mg Anmelden
Vergleichen
LY-­2562175 Inhibitors Other DCC-DC11547-1g

DCChemicals
1 g Anmelden
Vergleichen
WM-­8014 Inhibitors Other other DCC-DC10880-1g

DCChemicals
1 g Anmelden
Vergleichen
Balovaptan Inhibitors Other DCC-DC11516-100mg

DCChemicals
100 mg Anmelden
Vergleichen
WAY213613 Inhibitors Other IC DCC-DC11145-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Homo-­PROTAC pVHL30 degrader 1 Inhibitors Other ELISA DCC-DC11590-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Soticlestat Inhibitors Other DCC-DC11101-1g

DCChemicals
1 g Anmelden
Vergleichen
Balovaptan Inhibitors Other DCC-DC11516-250mg

DCChemicals
250 mg Anmelden
Vergleichen
WAY213613 Inhibitors Other IC DCC-DC11145-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Homo-­PROTAC pVHL30 degrader 1 Inhibitors Other ELISA DCC-DC11590-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Soticlestat Inhibitors Other DCC-DC11101-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Balovaptan Inhibitors Other DCC-DC11516-1g

DCChemicals
1 g Anmelden
Vergleichen
WAY213613 Inhibitors Other IC DCC-DC11145-1g

DCChemicals
1 g Anmelden
Vergleichen
Homo-­PROTAC pVHL30 degrader 1 Inhibitors Other ELISA DCC-DC11590-1g

DCChemicals
1 g Anmelden
Vergleichen
JAK2 inhibitor G5-­7 Inhibitors Other JAK2 inhibitor G5-7 is a small molecule, allosteric JAK2 inhibitor that selectively inhibits JAK2-mediated phosphorylation and activation of EGFR and STAT3 by binding to JAK2. DCC-DC11136-100mg

DCChemicals
100 mg Anmelden
Vergleichen
JAK2 inhibitor G5-­7 Inhibitors Other JAK2 inhibitor G5-7 is a small molecule, allosteric JAK2 inhibitor that selectively inhibits JAK2-mediated phosphorylation and activation of EGFR and STAT3 by binding to JAK2. DCC-DC11136-250mg

DCChemicals
250 mg Anmelden
Vergleichen
JAK2 inhibitor G5-­7 Inhibitors Other JAK2 inhibitor G5-7 is a small molecule, allosteric JAK2 inhibitor that selectively inhibits JAK2-mediated phosphorylation and activation of EGFR and STAT3 by binding to JAK2. DCC-DC11136-1g

DCChemicals
1 g Anmelden
Vergleichen
SR-­1664 Inhibitors Other IC, IV DCC-DC11750-100mg

DCChemicals
100 mg Anmelden
Vergleichen
SR-­1664 Inhibitors Other IC, IV DCC-DC11750-250mg

DCChemicals
250 mg Anmelden
Vergleichen
SR-­1664 Inhibitors Other IC, IV DCC-DC11750-1g

DCChemicals
1 g Anmelden
Vergleichen
mutant EGFR inhibitor B30 Inhibitors Other IC, other DCC-DC10915-10mg

DCChemicals
10 mg Anmelden
Vergleichen
LSZ-­102 Inhibitors Other LSZ102 is a potent, orally bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer. DCC-DC10755-10mg

DCChemicals
10 mg Anmelden
Vergleichen
LSZ-­102 Inhibitors Other LSZ102 is a potent, orally bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer. DCC-DC10755-25mg

DCChemicals
25 mg Anmelden
Vergleichen
LSZ-­102 Inhibitors Other LSZ102 is a potent, orally bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer. DCC-DC10755-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Razuprotafib Inhibitors Other Razuprotafib is a potent protein tyrosine phosphatase β (HPTPβ) inhibitor.. DCC-DC11528-5mg

DCChemicals
5 mg Anmelden
Vergleichen
Name Preis
BMS-­986120 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
LY-­2562175 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
WM-­8014 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 1 g
Lieferbar
Balovaptan Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
WAY213613 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
Homo-­PROTAC pVHL30 degrader 1 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. ELISA
Host
ArtNr.
Menge 100 mg
Lieferbar
Soticlestat Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
Balovaptan Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
WAY213613 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
Homo-­PROTAC pVHL30 degrader 1 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. ELISA
Host
ArtNr.
Menge 250 mg
Lieferbar
Soticlestat Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
Balovaptan Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
WAY213613 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
Homo-­PROTAC pVHL30 degrader 1 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. ELISA
Host
ArtNr.
Menge 1 g
Lieferbar
JAK2 inhibitor G5-­7 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. JAK2 inhibitor G5-7 is a small molecule, allosteric JAK2 inhibitor that selectively inhibits JAK2-mediated phosphorylation and activation of EGFR and STAT3 by binding to JAK2.
Host
ArtNr.
Menge 100 mg
Lieferbar
JAK2 inhibitor G5-­7 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. JAK2 inhibitor G5-7 is a small molecule, allosteric JAK2 inhibitor that selectively inhibits JAK2-mediated phosphorylation and activation of EGFR and STAT3 by binding to JAK2.
Host
ArtNr.
Menge 250 mg
Lieferbar
JAK2 inhibitor G5-­7 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. JAK2 inhibitor G5-7 is a small molecule, allosteric JAK2 inhibitor that selectively inhibits JAK2-mediated phosphorylation and activation of EGFR and STAT3 by binding to JAK2.
Host
ArtNr.
Menge 1 g
Lieferbar
SR-­1664 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC, IV
Host
ArtNr.
Menge 100 mg
Lieferbar
SR-­1664 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC, IV
Host
ArtNr.
Menge 250 mg
Lieferbar
SR-­1664 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC, IV
Host
ArtNr.
Menge 1 g
Lieferbar
mutant EGFR inhibitor B30 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC, other
Host
ArtNr.
Menge 10 mg
Lieferbar
LSZ-­102 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. LSZ102 is a potent, orally bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer.
Host
ArtNr.
Menge 10 mg
Lieferbar
LSZ-­102 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. LSZ102 is a potent, orally bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer.
Host
ArtNr.
Menge 25 mg
Lieferbar
LSZ-­102 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. LSZ102 is a potent, orally bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer.
Host
ArtNr.
Menge 100 mg
Lieferbar
Razuprotafib Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. Razuprotafib is a potent protein tyrosine phosphatase β (HPTPβ) inhibitor..
Host
ArtNr.
Menge 5 mg
Lieferbar

609594 Artikel

pro Seite